A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

During a live event, Lori Wirth, MD, discussed next steps for treating a patient with progressive, radioactive ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

Peter Rabins discusses 'The 36-Hour Day,' the seminal guide for caregivers of people with Alzheimer's and dementia ...

Transcutaneous afferent patterned stimulation is linked to metabolic activity changes in the cerebellum and other brain areas ...

Scientists at the Commonwealth Scientific and Industrial Research Organization (CSIRO) found that combining two blood tests, the Lumipulse plasma pTau217 test and the Aβ42/40 ratio test, could match ...

Galleri should have a good chance to win FDA marketing approval in early 2027. But insurance coverage and widespread adoption ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.